Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Presenter: Carlos Mena

REGISTER for free or LOG IN to view this content

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

We Recommend